Kevin O’Meara

Vice President, Patient Services


Affordability Programs (PAP, Copay), Client Services, Commercialization, Digital Technology, Hub & Adherence Solutions, Market Access, Patient Journey, Patient Services, Product Launch

Kevin O’Meara is a patient services leader who is driving change for clients and their patients. With more than 25 years in executive-level leadership roles, he understands the complexities behind access barriers, copay programs and reimbursement, and patient onboarding, and how program challenges affect the patient journey. More specifically, his experience focused on managed care and commercial operations, including copay programs and patient access programs positioned to drive prescription growth. At EVERSANA, Kevin works with clients to pave a pathway for patients and providers to access new and innovative treatments.

Kevin has a bachelor’s degree and an MBA from the University of Notre Dame.

Articles by Kevin O’Meara

Brand Planning – Fitting Financial and Copay Services into Existing Models

EVERSANA’s Kevin O’Meara, Vice President, Patient Services Solutions, Joe Bachstadt, Vice President, Patient Services Affordability, and Chris Lagoerio, Director, Revenue Management, presented a session, “Brand Planning – Fitting Financial and Copay Services into Existing Models,” at Informa Connect’s Copay, Reimbursement and Access Congress. Session Summary Since the early 2000s copay programs have evolved, becoming increasingly […]

Navigating the Complexities of Patient Care with Digital and Human Touchpoints

Three Key Objectives Guide Program Development: Access, Affordability and Adherence Patients taking branded therapies to manage long-term health conditions are faced with a dizzying array of challenges, all of which can hinder access to medication, create affordability challenges and undermine long-term adherence objectives. State-of-the-art wraparound support programs must be devised to help patients and their […]

Realign Access Strategies to Overcome Challenges of Co-pay Assistance and Cost Sharing Trends

Kevin O’Meara, EVERSANA’s Vice President of Patient Services Solutions, joined Peter Avalos, National Reimbursement Director at Daiichi Sankyo, Inc., to discuss the current challenges impeding patient access and how to best optimize your co-pay programs using customized solutions and digital innovations.

The Patient Access Paradox: How the New CMS Rule Could Prioritize Drug Pricing Before Clinical Decision-Making

In January 2023, co-pay programs will be put to the test, consequently examining how well your brand can adapt to the Final Rule changes to meet patient and provider needs. Our recommendation: Don’t wait – start solutioning a patient-centric approach to access and affordability now.

Interested in scheduling a meeting or speaking event?


  • This field is for validation purposes and should be left unchanged.